About ATRIPLA
ATRIPLA combines two nucleoside reverse transcriptase inhibitors (NRTIs) and one
non-nucleoside reverse transcriptase inhibitor (NNRTI) in one pill.
The first and still the only entire HIV regimen in one pill daily. ATRIPLA may be taken alone or with other HIV medicines.
With the power of three HIV medicines in one pill, ATRIPLA offers an entire HIV regimen in a single daily dose, for many patients.
ATRIPLA is the #1 prescribed HIV regimen.*
- ATRIPLA is the only 1 pill daily HIV regimen with 3 DHHS-preferred† meds for patients new to therapy
- ATRIPLA is proven to lower viral load to undetectable‡
and helps raise T-cell (CD4+) count to help control HIV through 3 years of
a
clinical study
in patients new to therapy.
- Through 3 years, 71% of patients taking the meds in ATRIPLA had undetectable‡ viral loads versus 58% for
COMBIVIR (lamivudine/zidovudine) + SUSTIVA
- At Year 3, the average increase of CD4+ cell count was 312 cells/mm3 for patients taking the meds in ATRIPLA versus 271 cells/mm3 for COMBIVIR + SUSTIVA
The long-term effects (beyond 3 years) of ATRIPLA are not known at this time. People taking ATRIPLA may still get opportunistic
infections or other conditions that happen with HIV-1 infection.
ATRIPLA does not cure HIV-1 and has not been shown to prevent passing HIV-1 to others.
Medicines you should not take with ATRIPLA:
Do not take ATRIPLA if you are taking the following medicines because serious and life-threatening side effects may occur when taken together: Vascor
® (bepridil),
Propulsid
® (cisapride), Versed
® (midazolam), Orap
® (pimozide), Halcion
® (triazolam), or ergot medications (for example, Wigraine
® and Cafergot
®).
In addition, ATRIPLA should not be taken with: Combivir
® (lamivudine/zidovudine),
EMTRIVA (emtricitabine), Epivir
® or Epivir-HBV
® (lamivudine),
Epzicom
® (abacavir sulfate/lamivudine), SUSTIVA (efavirenz),
Trizivir
® (abacavir sulfate/lamivudine/zidovudine),
TRUVADA (emtricitabine/tenofovir DF), or VIREAD (tenofovir DF), because they contain the same or similar active ingredients as ATRIPLA. ATRIPLA should not be used with
HEPSERA
® (adefovir dipivoxil).
Ask your doctor if ATRIPLA is right for you, and see your healthcare provider regularly. Individual results may vary.
Please
click here for Important Safety Information, including information on
lactic acidosis,
serious liver problems, and
flare-ups of hepatitis B virus (HBV).